Form D · Biotechnology
LS BIOPATH, INC.
Saratoga, CA · CIK 0001477519
Offering snapshot reported Jul 6, 2021 · SEC filing
- Reported sold
- $6.94M Offering amount: $8M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 6, 2021 | Initial | $6,941,661 | No comparison | Not reported | SEC filing |
| Mar 11, 2011 | Initial | $1,099,994 | No comparison | 10 | SEC filing |
| Nov 25, 2009 | Initial | $699,998 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-405327
Source: Form D, filed Jul 6, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rusmin Kudinar | Director |
| Amir Lev | Director, Executive |
| Jim Pfeiffer | Director |
| Moshe Sarfaty | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
18809 Cox Avenue Suite 140
Saratoga, CA, 95070
Saratoga, CA, 95070